Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5780 Target Snapshot

Sodium/nucleoside cotransporter 2 · SINGLE PROTEIN · Homo sapiens

69Compounds
17Assays
2Approved Drugs
67.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt O43868. Use UniProt O43868 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt O43868 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Sodium/nucleoside cotransporter 2 as ChEMBL target CHEMBL5780, mapped to UniProt O43868. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Sodium/nucleoside cotransporter 2
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL5780
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
O43868
Sodium/nucleoside cotransporter 2
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Sodium/nucleoside cotransporter 2 is the right protein anchor across sources, using UniProt O43868 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelSodium/nucleoside cotransporter 2
UniProt AccessionO43868
Component TypeProtein
Sequence Length658 aa

Sodium/nucleoside cotransporter 2

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Sodium/nucleoside cotransporter 2, mapped to UniProt O43868. Sequence length is 658 aa.

Mapped IDO43868
Review nameSodium/nucleoside cotransporter 2
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Approved
2
Phase III
Assay Mix

Activity Type Distribution

IC5064.0
KI3.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3808747 7.21 IC50 62.0 Preclinical
CHEMBL3427690 6.19 IC50 640.0 Preclinical
CHEMBL3809613 6.03 IC50 940.0 Preclinical
CHEMBL3809974 6.0 IC50 1000.0 Preclinical
CHEMBL3809075 5.96 IC50 1100.0 Preclinical
CHEMBL3809514 5.96 IC50 1100.0 Preclinical
CHEMBL3808410 5.92 IC50 1200.0 Preclinical
CHEMBL3809978 5.89 IC50 1300.0 Preclinical
CHEMBL3809204 5.89 IC50 1300.0 Preclinical
CHEMBL3809948 5.82 IC50 1500.0 Preclinical
Distribution

pChEMBL Value Distribution

13
5.0
12
5.5
4
6.0
0
6.5
1
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

17
Total Assays
41
Tested Compounds
2
Assay Types
Binding — 15 assays, 41 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 8 36 5.4
single protein format 7 5 5.1
ADME — 2 assays, 3 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 3 4.9
cell-based format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine